Linda Harmark | Director
Drug Safety Research Unit

Dr. Linda Härmark has over 20 years of experience in pharmacovigilance, spanning research, strategic leadership, and international collaboration. She began her career at the Netherlands Pharmacovigilance Centre Lareb, where she held senior roles including Head of Innovation and Deputy Director. Currently, she is Director of the Drug Safety Research Unit, leading studies on medicine and vaccine safety using real-world data. She is passionate about patient involvement in pharmacovigilance, where she has conducted research and contributed to CIOMS XI’s report on patient involvement. She is committed to advancing pharmacovigilance in LMICs, having coordinated the WHO Collaborating Centre for Patient reporting and Education in PV and served on the executive board of the EDCTP-funded PAVIA project. Linda has (co-)authored over 50 peer-reviewed publications. She serves on the steering committee of the European Chapter of ISoP bringing scientific depth and strategic insight to the evolving field of drug safety.